Pharmacokinetics and pharmacodynamics of imatinib in COVID-19 patients
N. Baalbaki (Amsterdam, Netherlands), J. Aman (Amsterdam, Netherlands), P. Bet (Amsterdam, Netherlands), E. Duijvelaar (Amsterdam, Netherlands), J. Twisk (Amsterdam, Netherlands), C. Longo (Amsterdam, Netherlands), K. Mahmoud (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), E. Swart (Amsterdam, Netherlands), H. Bogaard (Amsterdam, Netherlands), I. Bartelink (Amsterdam, Netherlands)
Source: International Congress 2022 – COVID treatments
Session: COVID treatments
Session type: Thematic Poster
Number: 2614
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Baalbaki (Amsterdam, Netherlands), J. Aman (Amsterdam, Netherlands), P. Bet (Amsterdam, Netherlands), E. Duijvelaar (Amsterdam, Netherlands), J. Twisk (Amsterdam, Netherlands), C. Longo (Amsterdam, Netherlands), K. Mahmoud (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), E. Swart (Amsterdam, Netherlands), H. Bogaard (Amsterdam, Netherlands), I. Bartelink (Amsterdam, Netherlands). Pharmacokinetics and pharmacodynamics of imatinib in COVID-19 patients. 2614
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|